MOSCOW (Reuters) – Russia plans to produce between 1. 5 million and 2 million doses according to the month of its possible COVID-19 vaccine until the end of the year, expanding production to 6 million doses according to the Month Array, said RIA news agency, the minister. Industry, Denis Manturov said sunday.
Large-scale testing of the vaccine, developed through the Gamaleya Institute in Moscow, should begin in Russia next week.
Writing through Polina Ivanova; Edited through David Goodman
All quotes were delayed for at least 15 minutes. See here for a complete list of operations and delays.
© 2020 Reuters. All rights are reserved.